Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | EXS74539 |
| Trade Name | |
| Synonyms | EXS 74539|EXS-74539|REC-4539|REC4539|REC 4539 |
| Drug Descriptions |
EXS74539 (REC-4539) is a reversible LSD1 inhibitor that modulates gene expression, which may lead to decreased tumor cell proliferation and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 6290). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| EXS74539 | EXS74539 | 0 | 1 |